Immunologic tolerance

Current Opinion in Hematology

Volumn 4, Issue 1, 1997, Pages 48-52

  Sarzotti, Marcella ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN SPECIFICITY; AUTOIMMUNITY; CELL MATURATION; CELL SPECIFICITY; CLONAL ANERGY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; REVIEW; SKIN GRAFT; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

EID: 0031050989     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199704010-00008     Document Type: Review

References (49)

1. Burnet FM, Fenner F: The production of antibodies. Melbourne, Australia: The MacMillan Co.; 1949.
2. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 1953, 172:603-606.
3. Kappler JW, Roehm N, Marrack P: T cell tolerance by clonal elimination in the thymus. Cell 1987, 49:273-280.
4. + thymocytes. Nature 1988, 333:742-746.
5. Lamb JR, Feldmann M: Essential requirement for major histocompatibllity complex in recognition in T cell tolerance induction. Nature 1984, 308:72-74.
6. Jenkins MK, Schwartz RH: Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 1987, 165:302-319.
7. Miller RG, Derry H: A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen. J Immunol 1979, 122:1502-1509.
8. Fink PJ, Rammensee HG, Bevan MJ: Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them. J Immunol 1984, 133:1775-1781.
9. Nossal GJV: Choices following antigen entry: antibody formation or immunologic tolerance? Ann Rev Immunol 1995, 13:1-27.
10. Klinman NR: The "clonal selection hypothesis" and current concepts of B cell tolerance. Immunity 1996, 5:189-195.
11. Stockinger B: Cytotoxic T-cell precursors revealed in neonatally tolerant mice. Proc Natl Acad Sci U S A 1984, 81:220-223.
12. Powell TJ Jr, Streilein JW: Neonatal tolerance induction by class II alloantigens activates IL-4 secreting tolerogen-responsive T cells. J Immunol 1990, 144:854-859.
13. Mohler KM, Streilein JW: Lymphokine production by MLR-reactive reaction lymphocytes obtained from normal mice and mice rendered tolerant of class II MHC antigens. Transplantation 1989, 47:625-631.
14. + maturation toward Th2 cells occurs in tolerant states.
15. Sprent J, Webb SR: Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol 1995, 7:196-205. A very interesting article on the factors controlling clonal deletion in the thymus and in the peripheral lymphoid tissues.
16. Blackman M, Kappler J, Marrack P: The role of the T cell receptor in positive and negative selection of developing T cells. Science 1990, 248:1335-1341.
17. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994, 372:100-103.
18. Pircher HP, Burki K, Lang R, Hengertner H, Zinkernhagel R: Tolerance induction in double-specific T-cell receptor transgenic mice varies with antigen. Nature 1989, 342:559-561.
19. Zal T, Volkmann A, Stockinger B: Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self antigen. J Exp Med 1994, 180:2089-2099.
20. Silverstein AM, Segal S: The ontogeny of antigen-specific T cells. J Exp Med 1975, 142:802-804.
21. Thorbecke GJ, Siskind GW, Goldberger N: The induction in mice of sensitization and immunological unresponsiveness by neonatal injection of bovine λ-globulin. J Immunol 1961, 87:147-152.
22. Johnson LL: Resistance to Toxoplasma gondii in mice infected as neonates or exposed in utero. Infect Immun 1994, 62:3075-3079.
23. Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996, 271:1723-1726. Demonstrates that the dogma that the neonatal period represents an ontogenic window exclusively for tolerance induction rather than induction of immune response is incorrect. See also Sarzotti et al. (Science 1996, 271:1726-1728) and Forsthuber et al. (Science 1996, 271:1728-1730).
24. Sarzotti M, Robbins DS, Hoffman PM: Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996, 271:1726-1728. Demonstrates that the dogma that the neonatal period represents an ontogenic window exclusively for tolerance induction rather than induction of immune response is incorrect. See also Ridge et al. (Science 1996, 271:1723-1726) and Forsthuber et al. (Science 1996, 271:1728-1730).
25. H2 immunity in neonatal mice. Science 1996, 271:1728-1730. Demonstrates that the dogma that the neonatal period represents an ontogenic window exclusively for tolerance induction rather than induction of immune responses is incorrect. See also Ridge et al. (Science 1996, 271:1723-1726) and Sarzotti et al. (Science 1996, 271:1726-1728).
26. Matzinger P: Tolerance, danger and the extended family. Annu Rev Immunol 1994, 12:991-1045.
27. Abramowicz D, Durez P, Gerard C, Donckier V, Amraoui Z, Velu T, Goldman M: Tolerance of vascularized allografts and mechanisms. Transplantation Proc 1993, 25:312-313.
28. Parish CR: The relationship between humoral and cell-mediated immunity. Transplant Rev 1972, 13:35-66.
29. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H: Establishment of stable, cell mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992, 257:539-542.
30. + T cells and the role of their cytokines in pregnancy and infection.
31. Sarzotti M, Dean TA, Remington MP, Ly CD, Furth PA, Robbins DS: Induction of CTL responses in newborn mice by DNA immunization. Vaccine, in press.
32. Rochen M, Racke M, Shevach EM: IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune diseases. Immunol Today 1996, 17:225-231. This article reviews the experimental basis for an antigen-specific therapeutic treatment of inflammatory autoimmune diseases. The approach utilizes the immune deviation of inflammatory Th1 responses mediated by anti-inflammatory, interleukin-4-producing responses.
33. Ashwell JD, Longo DL, Bridges SH: T-cell tumor elimination as result of T-cell receptor mediated activation. Science 1987, 237:61-64.
34. Russell JH: Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 1995, 7:382-388.
35. Moskophidis D, Lechner F, Pircher H, Zinkernagel R: Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993, 362:758-761.
36. Rocha B, Von Boehmer H: Peripheral selection of the T-cell repertoire. Science 1991, 251:1225-1228.
37. Kearney ER, Pape KA, Loh DY, Jenkins MK: Visualization of peptide-specific T-cell immunity and peripheral tolerance induction in vivo. Immunity 1994, 1:327-339.
38. Singer CG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994, 1:365-371.
39. Russell JH, Rush B, Weaver C, Wang R: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci U S A 1993, 90:4409-4413.
40. Gillette-Ferguson I, Sidman CL: A specific intracellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice. Eur J Immunol 1994, 24:1181-1185.
41. Schwartz RH: Models of T cell energy: is there a common molecular mechanism? J Exp Med 1996, 184:1-8. A very thorough commentary on the latest proposed mechanisms of murine and human T-cell anergy.
42. Boussiotis VA, Freeman GJ, Gray G, Gribben J, Nadler LM: B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 1993, 178:1753-1763.
43. + T cells. Science 1996, 271:1276-1278. The analysis of Ras activation in a murine Th1 clone during T-cell receptor stimulation in the absence of costimulation reveals a block early in the Ras signaling pathway, which may prevent interleukin-2 gene transcription in anergic T cells.
44. Kruisbeek AM, Amsen D: Mechanisms underlying T-cell tolerance. Curr Opin Immunol 1996, 8:233-244.
45. Finkelman FD: Relationships among antigen presentation, cytokines, immune deviation, and autoimmune diseases. J Exp Med 1995, 182:279-282.
46. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993, 151:1224-1234.
47. Qin L, Chavin KD, Tahara H, Ding Y, Favarro J, Woodward J, Lin J, Robbins PD, Lotze MT, Bromberg JS: Retrovirus-mediated transfer of viral interleukin-10 gene prolongs murine cardiac allograft survival. J Immunol 1996, 156:2316-2323.
48. + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 1995, 182:1579-1584. This report describes an elegant analysis of the effect of antigen dose on the development of Th1 versus Th2 responses in primary cultures of αβ T-cell receptor T cells and different types of antigen-presenting cells.
49. Zheng B, Han S, Zhu Q, Goldsby R, Kelsoe G: Distinct pathways for selection of antigen-specific T cells in the periphery. Nature, in press. This provocative article defines a novel differentiation pathway for peripheral T cells by demonstrating that germinal center T cells, like immature thymocytes, are prone to Fas-independent apoptosis and express high levels of Nur-77.